Editorial Foreword - Milnacipran: recent findings in depression
Stuart Montgomery1, Mike Briley2 1Imperial College School of Medicine, London, England, UK; 2NeuroBiz Consulting and Communication, Castres, FranceMilnacipran: recent findings in depressionMilnacipran is a serotonin and norepinephrine reuptake inhibitor (SNRI) which was first approved for the treatm...
Enregistré dans:
Auteurs principaux: | Stuart Montgomery, Mike Briley |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2010
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b865ead338664fdc9c611ed1c9f0f16d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Milnacipran: recent findings in depression
par: Guest editors: Stuart Montgomery (London, et autres
Publié: (2010) -
Treatment of patients with comorbid depression and diabetes with metformin and milnacipran
par: Peter Hofmann
Publié: (2010) -
Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
par: Alla Avedisova, et autres
Publié: (2009) -
Noradrenergic symptom cluster in depression
par: Montgomery S, et autres
Publié: (2011) -
Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
par: Kamijima K, et autres
Publié: (2013)